Espérie Burnet

Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis

Clémence Martin, Martine Reynaud‐Gaubert, Rébecca Hamidfar et al. · Journal of Cystic Fibrosis · 2022 · 63 citations

Transplantation, Advanced Lung Disease, Lung Transplant Candidates +6

Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease

Clémence Martin, Espérie Burnet, A. Ronayette-Preira et al. · Respiratory Medicine and Research · 2021 · 51 citations

Pulmonary Care, Advanced Lung Disease, Patient Perspectives +4

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Pierre‐Régis Burgel, Isabelle Sermet‐Gaudelus, Emmanuelle Girodon et al. · The Lancet Respiratory Medicine · 2024 · 36 citations · Full text

F508del Cftr Variant, Translational Research, Pulmonary Fibrosis +2

Targeted HIV Screening in Eight Emergency Departments: The DICI-VIH Cluster-Randomized Two-Period Crossover Trial

Judith Leblanc, Gilles Hejblum, Dominique Costagliola et al. · Annals of Emergency Medicine · 2017 · 31 citations · Full text

Preventive Medicine, Clinical Infectious Disease, Treatment And Prevention +7

Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease

Pierre‐Régis Burgel, Jean-Louis Paillasseur, I. Durieu et al. · Annals of the American Thoracic Society · 2024 · 30 citations